Integrated multiomic profiling of breast cancer in the Chinese population reveals patient stratification and therapeutic vulnerabilities
Leming Shi(Fudan University), Zhi‐Ming Shao(Shanghai Medical College of Fudan University), Lei-Jie Dai(Shanghai Medical College of Fudan University), Yuanting Zheng(Fudan University), Nakul M. Shah(James S. McDonnell Foundation), Weigang Ge, Anneleen Daemen, Guan-Hua Su(Shanghai Medical College of Fudan University), Qingwang Chen(Fudan University), Wanwan Hou(Fudan University), Naixin Zhang(Fudan University), Xi Jin(Shanghai Medical College of Fudan University), Virginia Kaklamani(The University of Texas at San Antonio Health Science Center), Yaqing Liu(Fudan University), Jingcheng Yang(Fudan University), Tong‐Ming Fu(United States Military Academy), Ding Ma(Shanghai Medical College of Fudan University), Ying Yu(Union Hospital), Charles M. Perou(Segeberger Kliniken), Cai‐Jin Lin(Shanghai Medical College of Fudan University), Claire F. Verschraegen, François Bertucci(Institut Paoli-Calmettes), Shen Zhao(Sun Yat-sen University), Yi Xiao(Nanjing Medical University), Ting Wang(James S. McDonnell Foundation), Wei Liu(Baylor College of Medicine), Wenjuan Zhang(Fudan University Shanghai Cancer Center), Jinxiu Shi, Chenglin Liu(Shanghai Medical College of Fudan University), Yi-Fan Zhou(Shanghai Medical College of Fudan University), Tiannan Guo(Westlake University), Wei Huang(Chinese National Human Genome Center), Chao You(Fudan University Shanghai Cancer Center)
Cited by 0
Related Papers
Pathological complete response and long-term clinical benefit in breast cancer: the CTNeoBC pooled analysis
|The Lancet|2014|4.7k
Immunohistochemical and Clinical Characterization of the Basal-Like Subtype of Invasive Breast Carcinoma
|Clinical Cancer Research|2004|2.7k
The MicroArray Quality Control (MAQC) project shows inter- and intraplatform reproducibility of gene expression measurements
|Nature Biotechnology|2006|2.2k